Bio-Techne Corporation (TECH)

Bio-Techne Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	139.92	180.57	172.57	199.09	146.63	100.89
Short-Term Investments	5.4	23.74	74.46	32.46	124.27	65.15
Cash & Cash Equivalents	145.31	204.31	247.03	231.55	270.89	166.03
Cash Growth	-7.56%	-17.29%	6.68%	-14.52%	63.16%	-8.65%
Receivables	227.89	218.47	194.55	145.39	122.53	137.47
Inventory	179.5	171.64	141.12	116.75	103.15	91.05
Other Current Assets	57.96	27.07	22.86	16.92	24.34	18.06
Total Current Assets	610.65	621.48	605.56	510.61	520.92	412.61
Property, Plant & Equipment	340.99	324.53	288.8	281.74	248.29	154.04
Goodwill and Intangibles	1,497	1,407	1,354	1,459	1,245	1,312
Other Long-Term Assets	272.14	285.3	46.83	11.58	13.52	5.67
Total Long-Term Assets	2,111	2,017	1,689	1,752	1,507	1,472
Total Assets	2,721	2,639	2,295	2,263	2,028	1,884
Accounts Payable	28.9	29.18	33.87	33.38	29.03	19.61
Deferred Revenue	30.11	23.07	23.41	19	13.05	9.08
Current Debt	12.98	11.2	24.43	24.1	22.04	12.5
Other Current Liabilities	77.84	65.06	94.32	75.8	42.56	60.79
Total Current Liabilities	149.82	128.51	176.02	152.28	106.67	101.99
Long-Term Debt	481.75	443.77	301.54	396.45	411.49	492.66
Other Long-Term Liabilities	75.22	99.9	116.23	142.99	128.24	124.18
Total Long-Term Liabilities	556.98	543.67	417.78	539.44	539.73	616.84
Total Liabilities	706.8	672.18	593.79	691.72	646.4	718.82
Total Debt	494.73	454.97	325.97	420.55	433.53	505.16
Debt Growth	4.38%	39.57%	-22.49%	-2.99%	-14.18%	49.01%
Retained Earnings	1,298	1,309	1,123	1,085	1,057	931.93
Comprehensive Income	-75.31	-66.06	-75.2	-57.29	-97.2	-83.52
Shareholders' Equity	2,014	1,967	1,702	1,563	1,381	1,166
Net Cash / Debt	-349.42	-250.66	-78.94	-189	-162.63	-339.13
Net Cash Per Share	-2.18	-1.55	-0.48	-1.17	-1.03	-2.18
Working Capital	460.83	492.97	429.54	358.32	414.25	310.62
Book Value Per Share	12.80	12.51	10.85	10.09	9.04	7.71

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).